Current medical management of gastroesophageal reflux disease

Thoracic Surgery Clinics

Volumn 15, Issue 3 SPEC. ISS., 2005, Pages 369-375

  Locke III, G Richard ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; ZEGIRID;

AMBULATORY MONITORING; BARIATRIC SURGERY; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY CARE; COMORBIDITY; CONSERVATIVE TREATMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DYSPEPSIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HEALTH CARE MANAGEMENT; HEARTBURN; HELICOBACTER PYLORI; HUMAN; LIFESTYLE; LONG TERM CARE; OBESITY; PH MEASUREMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; STOMACH CANCER; STOMACH CARCINOGENESIS; SYMPTOM; TREATMENT INDICATION;

EID: 20544457235     PISSN: 15474127     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thorsurg.2005.04.004     Document Type: Review

References (51)

1. P.J. Kahrilas Gastroesophageal reflux disease JAMA 276 1996 983 988
2. K.R. DeVault, and D.O. Castell Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology Am J Gastroenterol 94 1999 1434 1442
3. J. Dent, J. Brun, and A.M. Fendrick An evidence-based appraisal of reflux disease management-the Genval Workshop Report Gut 44 1999 S1 S16
4. J. Dent, R. Jones, and P.J. Kahrilas Management of gastro-oesophageal reflux disease in general practice BMJ 322 2001 344 347
5. G.R. Locke III The epidemiology of functional gastrointestinal disorders in North America Gastroenterol Clin North Am 25 1996 1 19
6. L.I. Kitchin, and D.O. Castell Rationale and efficacy of conservative therapy for gastroesophageal reflux disease Arch Intern Med 151 1991 448 454
7. J.E. Numans, J. Lau, and M.J. de Wit Short-term treatment with proton pump inhibitors as a test for gastroesophageal reflux disease Ann Intern Med 140 2004 518 527
8. C. Goodman, K. Cronin, and E. Gemmen The burden of gastrointestinal diseases 2001 American Gastroenterological Association Bethesda (MD)
9. R. Fass, and G. Tougas Functional heartburn: the stimulus, the pain, and the brain Gut 51 2002 885 892
10. S.R. Achem Endoscopy-negative gastroesophageal reflux disease. The hypersensitive esophagus Gastroenterol Clin North Am 28 1999 893 904
11. R. Fass, M.B. Fennerty, and N. Vakil Nonerosive reflux disease-current concepts and dilemmas Am J Gastroenterol 96 2001 303 314
12. D. Sifrem, D. Castell, and J. Dent Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux Gut 53 2004 1024 1031
13. W.J. Blot, S.S. Devesa, and R.W. Kneller Rising incidence of adenocarcinoma of the esophagus and gastric cardia JAMA 265 1991 1287 1289
14. Nandurkar S., Locke III G.R., Murray J.A., et al. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol, in press
15. G.R. Locke III Natural history of nonerosive reflux disease - Is all gastroesophageal reflux disease the same? What is the evidence? Gastroenterol Clin North Am 31 2002 S59 S66
16. G.R. Locke III, N.J. Talley, and S.L. Fett Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota Gastroenterology 112 1997 1448 1456
17. L.I. Andersen, and G. Jensen Prevalence of benign oesophageal disease in the Danish population with special reference to pulmonary disease J Intern Med 1989 1989 393 401
18. R. Johnsen, B. Bernersen, and B. Straume Prevalences of endoscopic and histological findings in subjects with and without dyspepsia BMJ 302 1991 749 752
19. A. Ruigomez, L.A. Garcia Rodriguez, and M.A. Wallander Natural history of gastro-oesophageal reflux disease diagnosed in general practice Aliment Pharmacol Thera 20 2004 751 760
20. D.A. Revicki, M. Wood, and P.N. Maton The impact of gastroesophageal reflux disease on health-related quality of life Am J Med 104 1998 252 258
21. G.R. Locke III, N.J. Talley, and S.L. Fett Risk factors associated with symptoms of gastroesophageal reflux Am J Med 106 1999 642 649
22. S. Nandurkar, G.R. Locke III, and S.L. Fett Relationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a community Aliment Pharmacol Thera 20 2004 497 505
23. E.J. Patterson, D.G. Davis, and Y. Khajanchee Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn Surg Endosc 17 2003 1561 1565
24. B.D. Naliboff, M. Mayer, and R. Fass The effect of life stress on symptoms of heartburn Psychosom Med 66 2004 426 434
25. C.W. Howden, J.M. Henning, and B. Huang Management of heartburn in a large randomized community based study: comparison of four therapeutic strategies Am J Gastroenterol 96 2001 1704 1710
26. B.B. Dean, A.D. Gano Jr, and K. Knight Effectiveness of proton pump inhibitors in nonerosive reflux disease Clin Gastroenterol Hepatol 2 2004 656 664
27. P.O. Katz Optimizing medical therapy for gastroesophageal reflux disease: state of the art Rev Gastroenterol Disord 3 2003 59 69
28. P.K. Blustein, P.L. Beck, and J.B. Meddings The utility of endoscopy in the management of patients with gastroesophageal reflux symptoms Am J Gastroenterol 93 1998 2508 2512
29. G.R. Locke III, A.R. Zinsmeister, and N.J. Talley Can symptoms predict endoscopic findings in GERD? Gastrointest Endosc 58 2003 661 670
30. R.E. Sampliner Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus Am J Gastroenterol 97 2002 1888 1895
31. S. Vigneri, R. Termini, and G. Leandro A comparison of five maintenance therapies for reflux esophagitis N Engl J Med 333 1995 1106 1110
32. A.S. Arora, J. Perrault, and T.C. Smyrk Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults Mayo Clin Proc 78 2003 830 835
33. P. Malfertheiner, and U. Peitz The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia Gut 54 2005 i3 i20
34. J.J. Vicari, R.M. Peek, and G.W. Falk The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesphageal reflux disease Gastroenterology 115 1998 50 57
35. C. de Martel, A.E. Llosa, and S.M. Farr Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma J Infect Dis 191 2005 761 767
36. P. Moayyedi, C. Bardhan, and L. Young Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease Gastroenterology 121 2001 1120 1126
37. J. Labenz Protagonist: should we eradicate Helicobacter pylori before long-term antireflux therapy? Gut 49 2001 614 616
38. D. Forman, and D.Y. Graham Impact of Helicobacter pylori on society-role for a strategy of 'search and eradicate' Aliment Pharmacol Thera 19 2004 17 21
39. R. Fass Empirical trials in treatment of gastroesophageal reflux disease Dig Dis 18 2000 20 26
40. S. Charbel, F. Khandwala, and M.F. Vaezi The role of esophageal pH monitoring in symptomatic patients on PPI therapy Gastroenterology 100 2005 283 289
41. J.E. Pandolfino, J.E. Richter, and T. Ours Ambulatory esophageal pH monitoring using a wireless system Am J Gastroenterol 98 2003 740 749
42. G.R. Locke III, A.R. Zinsmeister, and S.L. Fett Overlap of gastrointestinal symptom complexes in a US community Neurogastroenterol Motil 17 2005 29 34
43. A.G. Klauser, N.E. Schindlbeck, and S.A. Muller-Lissner Symptoms in gastro-oesophageal reflux disease Lancet 335 1990 205 208
44. D. Castell, J.A. Murray, and R. Tutuian The pathophysiology of gastro-oesophageal reflux disease-oesophageal manifestations Aliment Pharmacol Thera 20 2004 14 25
45. R.A. Kozarek, D.E. Low, and S.L. Raltz Complications associated with laparoscopic anti-reflux surgery: one multispecialty clinic's experience Gastrointest Endosc 46 1997 527 531
46. J.M. Inadomi, L. McIntyre, and L. Bernard Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs Am J Gastroenterol 98 2003 1940 1944
47. N. Vakil, and M.B. Fennerty Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastroesophageal reflux disease and peptic ulcer disease Aliment Pharmacol Thera 18 2003 559 568
48. E.C. Klinkenberg-Knol, H.P. Festen, and J.B. Jansen Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety Ann Intern Med 121 1994 161 167
49. R.J.F. Laheij, M.C.J.M. Sturkenboom, and R.J. Hassing Risk of community acquired pneumonia and use of gastric acid suppressive drugs JAMA 292 2004 1955 1960
50. P. Bytzer, A. Blum, and D. De Herdt Six month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with nonerosive reflux disease Aliment Pharmacol Thera 20 2004 181 188
51. F. Johnsson, B. Moum, and M. Vilien On demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole Scand J Gastroenterol 37 2002 642 647